» Articles » PMID: 32515250

Curcumin Potentiates Laryngeal Squamous Carcinoma Radiosensitivity Via NF-ΚB Inhibition by Suppressing IKKγ Expression

Overview
Publisher Informa Healthcare
Date 2020 Jun 10
PMID 32515250
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Curcumin has shown efficacy in promoting radiosensitivity combined with radiotherapy. However, the role and mechanism of curcumin on radiosensitivity in laryngeal squamous cell cancer (LSCC) is largely unknown. The aim of our study is to explore the role of IKKγ-NF-κB signaling in curcumin enhancing LSCC cell radiosensitivity . Curcumin and X-ray were used to induce cell DNA damage and apoptosis, or inhibit cell clone formation. IKKγ siRNA and plasmid were used to change IKKγ expression. The CCK8 assay was used to detect cell viability. Clone formation ability was analyzed using a clonogenic assay, cell apoptosis was examined using flow cytometry, an immunofluorescence assay was used to detect DNA damage, while mRNA and protein levels were assayed using real time PCR and western blotting, respectively. Curcumin significantly enhanced irradiation-induced DNA damage and apoptosis, while weakening clone-forming abilities of LSCC cell line Hep2 and Hep2-max. Compared to Hep2 cells, Hep2-max cells are more sensitive to curcumin post-irradiation. Curcumin suppressed irradiation-induced NF-κB activation by suppressing IKKγ expression, but not IKKα and IKKβ. Overexpression of IKKγ decreased irradiation-induced DNA damage and apoptosis, while promoting clone-forming abilities of Hep2 and Hep2-max cells. IKKγ overexpression further increased expression of NF-κB downstream genes, Bcl-XL, Bcl-2, and cyclin D1. Conversely, IKKγ silencing enhanced irradiation-induced DNA damage and apoptosis, but promoted clone formation in Hep2 and Hep2-max cells. Additionally, IKKγ silencing inhibited expression of Bcl-XL, Bcl-2, and cyclin D1. Curcumin enhances LSCC radiosensitivity NF-ΚB inhibition by suppressing IKKγ expression.

Citing Articles

Exploring the molecular mechanism of cancer radiosensitization: the impact of physical stimulation therapy.

Liu S, Li M, Guo Z, Chen Z Strahlenther Onkol. 2025; .

PMID: 40067453 DOI: 10.1007/s00066-025-02385-0.


Curcumin: A Potential Weapon in the Prevention and Treatment of Head and Neck Cancer.

Vesela K, Kejik Z, Masarik M, Babula P, Dytrych P, Martasek P ACS Pharmacol Transl Sci. 2024; 7(11):3394-3418.

PMID: 39539276 PMC: 11555516. DOI: 10.1021/acsptsci.4c00518.


Synergistic effects of curcumin and stem cells on spinal cord injury: a comprehensive review.

Arefnezhad R, Jahandideh A, Rezaei M, Khatouni M, Zarei H, Jahani S Mol Biol Rep. 2024; 51(1):1113.

PMID: 39485550 DOI: 10.1007/s11033-024-10057-y.


Curcumin Nanoparticles-related Non-invasive Tumor Therapy, and Cardiotoxicity Relieve.

Cheng Y, Xu Q, Yu M, Dang C, Deng L, Chen H Curr Med Chem. 2024; 32(3):447-467.

PMID: 38918994 PMC: 11826934. DOI: 10.2174/0109298673305616240610153554.


Curcumin suppresses the malignant phenotype of laryngeal squamous cell carcinoma through downregulating E2F1 to inhibit FLNA.

Xie Y, Qi J, Liu J Naunyn Schmiedebergs Arch Pharmacol. 2024; 397(9):6929-6939.

PMID: 38592439 DOI: 10.1007/s00210-024-03059-x.